AAP IMPLANTATE (AAQ1.DE) Stock Price & Overview

FRA:AAQ1 • DE000A3H2101

Current stock price

1.39 EUR
+0.03 (+2.21%)
Last:

The current stock price of AAQ1.DE is 1.39 EUR. Today AAQ1.DE is up by 2.21%. In the past month the price decreased by -2.11%. In the past year, price decreased by -22.78%.

AAQ1.DE Key Statistics

52-Week Range1.08 - 2
Current AAQ1.DE stock price positioned within its 52-week range.
1-Month Range1.31 - 1.52
Current AAQ1.DE stock price positioned within its 1-month range.
Market Cap
20.461M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.35
Dividend Yield
N/A

AAQ1.DE Stock Performance

Today
+2.21%
1 Week
-2.80%
1 Month
-2.11%
3 Months
+1.46%
Longer-term
6 Months -14.72%
1 Year -22.78%
2 Years +19.83%
3 Years -0.71%
5 Years -46.12%
10 Years N/A

AAQ1.DE Stock Chart

AAP IMPLANTATE / AAQ1 Daily stock chart

AAQ1.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to AAQ1.DE. When comparing the yearly performance of all stocks, AAQ1.DE is a bad performer in the overall market: 84.96% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AAQ1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AAQ1.DE. While AAQ1.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AAQ1.DE Earnings

Next Earnings DateApr 30, 2026
Last Earnings DateN/A
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

AAQ1.DE Forecast & Estimates

For the next year, analysts expect an EPS growth of 65% and a revenue growth 15.38% for AAQ1.DE


Analysts
Analysts42.22
Price TargetN/A
EPS Next Y65%
Revenue Next Year15.38%

AAQ1.DE Groups

Sector & Classification

Index Membership

AAQ1.DE Financial Highlights

Over the last trailing twelve months AAQ1.DE reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 63.21% compared to the year before.


Income Statements
Revenue(TTM)12.20M
Net Income(TTM)-3.63M
Industry RankSector Rank
PM (TTM) N/A
ROA -25.96%
ROE -38.7%
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%21.53%
Sales Q2Q%-3.32%
EPS 1Y (TTM)63.21%
Revenue 1Y (TTM)6.32%

AAQ1.DE Ownership

Ownership
Inst Owners22.38%
Shares14.72M
Float5.62M
Ins Owners15.97%
Short Float %N/A
Short RatioN/A

About AAQ1.DE

Company Profile

AAQ1 logo image aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 90 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.

Company Info

IPO: 1999-05-10

AAP IMPLANTATE

Lorenzweg 5

Berlin BERLIN DE

Employees: 90

AAQ1 Company Website

AAQ1 Investor Relations

Phone: 4930750190

AAP IMPLANTATE / AAQ1.DE FAQ

What does AAQ1 do?

aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 90 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.


What is the stock price of AAP IMPLANTATE today?

The current stock price of AAQ1.DE is 1.39 EUR. The price increased by 2.21% in the last trading session.


Does AAP IMPLANTATE pay dividends?

AAQ1.DE does not pay a dividend.


What is the ChartMill rating of AAP IMPLANTATE stock?

AAQ1.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the number of employees for AAP IMPLANTATE?

AAP IMPLANTATE (AAQ1.DE) currently has 90 employees.